Literature DB >> 1312305

Glioblastoma, transforming growth factor-beta, and Candida meningitis: a potential link.

P K Peterson1, C C Chao, S Hu, K Thielen, E G Shaskan.   

Abstract

The development of Candida meningitis in a patient following partial resection of a glioblastoma raised suspicion that transforming growth factor (TGF-beta), an immunosuppressive cytokine known to be produced by this tumor, would be elevated in his cerebrospinal fluid (CSF). By using a highly specific bioassay, the concentration of TGF-beta was found to be 609 pg/mL, which was 10-fold greater than the mean CSF TGF-beta value in control subjects with no neurologic disease. Increased CSF TGF-beta levels were also detected in patients with other central nervous system (CNS) diseases: malignancies and AIDS dementia complex. These findings suggest that TGF-beta may play an immunopathogenetic role in the CNS.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1312305     DOI: 10.1016/0002-9343(92)90075-m

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  6 in total

1.  Increased concentrations of transforming growth factor beta1 and beta2 in the plasma of patients with glioblastoma.

Authors:  Thomas Schneider; Michael Sailer; Siegfried Ansorge; Raimund Firsching; Dirk Reinhold
Journal:  J Neurooncol       Date:  2006-04-14       Impact factor: 4.130

2.  Effects of transforming growth factor-beta on murine astrocyte glutamine synthetase activity. Implications in neuronal injury.

Authors:  C C Chao; S Hu; M Tsang; J Weatherbee; T W Molitor; W R Anderson; P K Peterson
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

3.  Serum cytokine levels in patients with Alzheimer's disease.

Authors:  C C Chao; T A Ala; S Hu; K B Crossley; R E Sherman; P K Peterson; W H Frey
Journal:  Clin Diagn Lab Immunol       Date:  1994-07

4.  Increased levels of interferon-gamma (IFN-gamma), IL-4 and transforming growth factor-beta (TGF-beta) mRNA expressing blood mononuclear cells in human HIV infection.

Authors:  V Navikas; J Link; B Wahren; C Persson; H Link
Journal:  Clin Exp Immunol       Date:  1994-04       Impact factor: 4.330

5.  A mathematical model to elucidate brain tumor abrogation by immunotherapy with T11 target structure.

Authors:  Sandip Banerjee; Subhas Khajanchi; Swapna Chaudhuri
Journal:  PLoS One       Date:  2015-05-08       Impact factor: 3.240

6.  Modeling the Treatment of Glioblastoma Multiforme and Cancer Stem Cells with Ordinary Differential Equations.

Authors:  Kristen Abernathy; Jeremy Burke
Journal:  Comput Math Methods Med       Date:  2016-01-18       Impact factor: 2.238

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.